Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
Kwang‐Hoon Chun
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1380-1380
Open Access | Times Cited: 25

Showing 25 citing articles:

Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
Amogh Gupta, Dipanwita Das, Reshma Taneja
Cancers (2024) Vol. 16, Iss. 7, pp. 1313-1313
Open Access | Times Cited: 14
Immunomodulatory role of metalloproteinase ADAM17 in tumor development
Kai Wang, Zixue Xuan, Xiaoyan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Consequences of genetic variants in miRNA genes
Magdalena Machowska, Paulina Galka-Marciniak, Piotr Kozłowski
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 6443-6457
Open Access | Times Cited: 24
Role of miRNA‑122 in cancer (Review)
Jing Zhang, Linghua Wu, Rong Ding, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 4
Early total care and damage control orthopaedics result in partially contrasting patterns of microRNA expression at the fracture site and in the systemic circulation
Rald V. M. Groven, Ümit Mert, Johannes Greven, et al.
The Bone & Joint Journal (2025) Vol. 107-B, Iss. 2, pp. 193-203
Closed Access
Strategies for discovering novel hepatocellular carcinoma biomarkers
Shang‐Gin Wu, Li Zhu, Xiaoling Feng, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 2
Closed Access
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
Han Qin, Mengchen Wang, Xi Dong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review
Mah I Kan Changez, Maryam Mubeen, Monezahe Zehra, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 9
Open Access | Times Cited: 11
Salvianolic acid B from Salvia miltiorrhiza bunge: A potential antitumor agent
Shasha Guo, Zhenguo Wang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Identifying alkaline phosphatase inhibitory potential of cyclooxygenase-2 inhibitors: Insights from molecular docking, MD simulations, molecular expression analysis in MCF-7 breast cancer cell line and in vitro investigations
Saddam Hussain, Ambar Iqbal, Sujhla Hamid, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 132721-132721
Closed Access | Times Cited: 3
Long noncoding RNA 02027 inhibits proliferation, migration and invasion of hepatocellular carcinoma via miR‐625‐3p/PDLIM5 pathway
Jinyi Wang, Yong Zhu, Xiaoming Ai, et al.
The Journal of Gene Medicine (2023) Vol. 25, Iss. 6
Closed Access | Times Cited: 8
Specific miRNAs are associated with human cancer cachexia in an organ‐specific manner
Tanja Krauss, Simone Heisz, Julius Honecker, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 3, pp. 1381-1394
Open Access | Times Cited: 8
Advances in experimental animal models of hepatocellular carcinoma
Jing Li, Xin Wang, Mudan Ren, et al.
Cancer Medicine (2023) Vol. 12, Iss. 14, pp. 15261-15276
Open Access | Times Cited: 8
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
Matheus Truccolo Michalczuk, Larisse Longo, Melina Belén Keingeski, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 1, pp. 75-90
Open Access | Times Cited: 2
Novel insights into the impact of liver inflammatory responses on primary liver cancer development
Yeni Ait Ahmed, Fouad Lafdil
Liver Research (2023) Vol. 7, Iss. 1, pp. 26-34
Open Access | Times Cited: 6
Risk factors of primary liver cancer initiation associated with tumour initiating cell emergence: novel targets for promising preventive therapies
Arthur Brouillet, Fouad Lafdil
eGastroenterology (2023) Vol. 1, Iss. 1, pp. e100010-e100010
Open Access | Times Cited: 5
Dual Roles of microRNA-122 in Hepatocellular Carcinoma and Breast Cancer Progression and Metastasis: A Comprehensive Review
Essam Al Ageeli
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 11975-11992
Open Access | Times Cited: 1
MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies
Sharmila Fagoonee, Ralf Weiskirchen
Cells (2024) Vol. 13, Iss. 23, pp. 1935-1935
Open Access | Times Cited: 1
miRNAs in HCC, pathogenesis, and targets
Guisheng Song, Xiaofan Yu, Hongtao Shi, et al.
Hepatology (2024)
Closed Access | Times Cited: 1
Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR‐122
Y. Liang, Yu‐Wei Chiou, Abby P. Chiu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Closed Access | Times Cited: 2
The Role of miR-155 and miR-122 in Valproic Acid-Induced Liver Injury
Narges Pashmforoosh, Mohammad Rashno, Masoumeh Baradaran
Jundishapur Journal of Natural Pharmaceutical Products (2024) Vol. 19, Iss. 3
Open Access
MicroRNA-122 regulates inflammatory and autophagic proteins by downregulating pyruvate kinase M2 in non-alcoholic fatty liver disease
Md. Musa Hossain, Amit Mishra, Ajay K. Yadav, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access
Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
Junqi You, Haoming Xia, Ziyue Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Circulating Plasma miR-122 and miR-583 Levels Are Involved in Chronic Hepatitis B Virus Pathogenesis and Serve As Novel Diagnostic Biomarkers
Fedra Mokhtari, Hami Kaboosi, Seyed Reza Mohebbi, et al.
Genetic Testing and Molecular Biomarkers (2023) Vol. 27, Iss. 8, pp. 232-238
Closed Access | Times Cited: 1
miR-122 and miR-21 as clinical biomarkers in hepatocellular carcinoma: A review
Nishant Kumar, Priyvart Choudhary, Narotam Sharma, et al.
Journal of Applied Biology & Biotechnology (2023)
Open Access
Page 1

Scroll to top